CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Definition and Management of Segmental Pulmonary Hypertension Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club Influence of Heart Rate on FFR Measurements: An Experimental and Clinical Validation Study Pulmonary hypertension related to congenital heart disease: a call for action Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention Evolving understanding of the heterogeneous natural history of individual coronary artery plaques and the role of local endothelial shear stress Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and D6PK Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture Pulmonary Hypertension Caused by a Coconut Left Atrium ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association

Clinical Trial2019 Jan 15;139(3):325-333.

JOURNAL:Circulation. Article Link

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease

Kufner S, Joner M, ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents) Investigators. Keywords: biodegradable polymer; drug-eluting stent; permanent polymer; randomized clinical trial

FULL TEXT PDF